Loading…
quant Consumption Fund (earlier scheme)
Disclosed for 35 months, Jan 2019 to Nov 2021. This scheme is no longer reporting.
Portfolio value
₹68 L
up ₹0 L vs Dec 2019
- Stocks held
- 20
- up 1 vs Dec 2019
- Top 10 weight
- 67.1%
- of the portfolio in its ten largest
- Cash & debt
- 4.4%
- cash, money market and debt
quant Consumption Fund (earlier scheme) is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In January 2020 it disclosed 20 stocks worth ₹68 L, up ₹0 L from Dec 2019. Its largest positions were Nippon Life India Asset Management Limited (8.0%), ICICI Prudential Life Insurance Company Limited (7.7%), Bandhan Bank Limited (7.5%); the ten largest together made up 67.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 19.8% of its equity. Cash and debt stood at 4.4%. Compared with Dec 2019 the fund entered 10 new stocks and exited 9.
Against 230 other Sectoral / Thematic funds
Concentration
92%
Top-10 weight is higher than 92% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
63%
Holds more cash than 63% of peers
What these mean: concentration · cash
Holdings in January 2020
Download CSVEvery line the fund disclosed, with the change against Dec 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Nippon Life India Asset Management Limited | 7.97% | up 0.20 pts | ₹5 L | up ₹0 L | Added |
| ICICI Prudential Life Insurance Company Limited | 7.69% | up 0.43 pts | ₹5 L | up ₹0 L | Added |
| Bandhan Bank Limited | 7.48% | down 0.97 pts | ₹5 L | down ₹1 L | Trimmed |
| Godrej Agrovet Limited | 7.19% | down 2.50 pts | ₹5 L | down ₹2 L | Trimmed |
| ICICI Bank Limited | 6.94% | up 6.94 pts | ₹5 L | up ₹5 L | New |
| Godrej Consumer Products Limited | 6.90% | up 2.65 pts | ₹5 L | up ₹2 L | Added |
| CreditAccess Grameen Limited | 6.20% | up 0.25 pts | ₹4 L | up ₹0 L | Added |
| Biocon Limited | 5.80% | up 0.01 pts | ₹4 L | up ₹0 L | Held |
| Sun Pharmaceutical Industries Limited | 5.77% | up 5.77 pts | ₹4 L | up ₹4 L | New |
| Reliance Industries Limited | 5.21% | up 5.21 pts | ₹4 L | up ₹4 L | New |
| Cash, TREPS & receivables | 4.36% | down 6.29 pts | ₹3 L | down ₹4 L | Trimmed |
| GlaxoSmithKline Pharmaceuticals Limited | 4.18% | up 4.18 pts | ₹3 L | up ₹3 L | New |
| Grasim Industries Limited | 3.85% | up 0.17 pts | ₹3 L | up ₹0 L | Added |
| Mahindra & Mahindra Limited | 3.85% | up 0.24 pts | ₹3 L | up ₹0 L | Added |
| Dhanuka Agritech Limited | 3.42% | up 3.42 pts | ₹2 L | up ₹2 L | New |
| Alembic Pharmaceuticals Limited | 3.16% | up 3.16 pts | ₹2 L | up ₹2 L | New |
| SBI Life Insurance Company Limited | 3.08% | up 3.08 pts | ₹2 L | up ₹2 L | New |
| IIFL Finance Limited | 2.84% | up 2.84 pts | ₹2 L | up ₹2 L | New |
| Dr. Lal Path Labs Limited | 1.70% | up 1.70 pts | ₹1 L | up ₹1 L | New |
| Hero MotoCorp Limited | 1.48% | up 1.48 pts | ₹1 L | up ₹1 L | New |
| Raymond Limited | 0.95% | down 0.04 pts | ₹1 L | down ₹0 L | Trimmed |
What changed, Dec 2019 to Jan 2020
New New positions (10)
- ICICI Bank Limited6.9% · ₹5 L
- Sun Pharmaceutical Industries Limited5.8% · ₹4 L
- Reliance Industries Limited5.2% · ₹4 L
- GlaxoSmithKline Pharmaceuticals Limited4.2% · ₹3 L
- Dhanuka Agritech Limited3.4% · ₹2 L
- Alembic Pharmaceuticals Limited3.2% · ₹2 L
- SBI Life Insurance Company Limited3.1% · ₹2 L
- IIFL Finance Limited2.8% · ₹2 L
- Dr. Lal Path Labs Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2019, the weight rose most in Pharmaceuticals & Biotechnology (+13.3 pts) and Petroleum Products (+5.4 pts), and fell most in Insurance (−12.6 pts) and Food Products (−5.8 pts).
- Pharmaceuticals & Biotechnology6.5% → 19.8%+13.3 pts
- Petroleum Products0.0% → 5.4%new+5.4 pts
- Fertilizers & Agrochemicals0.0% → 3.6%new+3.6 pts
- Finance6.7% → 9.5%+2.8 pts
- Automobiles4.0% → 5.6%+1.5 pts
- Insurance23.8% → 11.3%−12.6 pts
- Food Products13.3% → 7.5%−5.8 pts
- Healthcare Services5.4% → 1.8%−3.6 pts
- Personal Products9.6% → 7.2%−2.4 pts
- Banks16.7% → 15.1%−1.7 pts
- Capital Markets8.7% → 8.3%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2019 | Jul 2019 | Oct 2019 | Dec 2019 | Jan 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 2.1% | 6.4% | 2.5% | 6.5% | 19.8% |
| Banks | 40.6% | 22.0% | 12.3% | 16.7% | 15.1% |
| Insurance | — | 18.9% | 24.1% | 23.8% | 11.3% |
| Finance | — | — | 4.9% | 6.7% | 9.5% |
| Capital Markets | — | 6.5% | 9.8% | 8.7% | 8.3% |
| Food Products | 6.4% | 6.0% | 12.3% | 13.3% | 7.5% |
| Personal Products | — | 8.8% | 12.6% | 9.6% | 7.2% |
| Automobiles | 3.0% | — | 3.0% | 4.0% | 5.6% |
| Petroleum Products | — | — | — | — | 5.4% |
| Cement & Cement Products | — | 4.3% | — | 4.1% | 4.0% |
Allocation in Jan 2020change vs Dec 2019
- Pharmaceuticals & Biotechnology (4)19.8%▲ 13.3 pts
- Banks (2)15.1%▼ 1.7 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2020
4.4%
▼ 6.3 pts vs Dec 2019
- Cash alone
- 4.4%
- cash and net receivables
- A year earlier
- 4.0%
- Jan 2019 · now ▲ 0.3 pts
- Last 12 months
- −0.5% – 18.3%
- lowest to highest · record 18.3% in Mar 2019
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.